Results 171 to 180 of about 1,251,853 (222)

Lymphatic dysfunction and ZFP36 deficiency contribute to myxomatous valve degeneration in Marfan syndrome mice. [PDF]

open access: yesJ Clin Invest
Tan C   +9 more
europepmc   +1 more source

Efficacy and safety of atrial fibrillation ablation in patients with Marfan syndrome: A multicenter analysis. [PDF]

open access: yesHeart Rhythm O2
Nabi HA   +8 more
europepmc   +1 more source

Cardiac surgical outcomes and predictors of redo sternotomy in patients with Marfan syndrome: a retrospective multicentre cohort study. [PDF]

open access: yesOpen Heart
Abdul Nabi H   +10 more
europepmc   +1 more source

Pain Hypersensitivity in a Mouse Model of Marfan Syndrome. [PDF]

open access: yesAntioxidants (Basel)
Kordikowski R   +7 more
europepmc   +1 more source

A multiscale computational model of ascending thoracic aortic aneurysm development in Marfan syndrome for in silico trials. [PDF]

open access: yesBiomech Model Mechanobiol
Jansen L   +6 more
europepmc   +1 more source

Marfan's Syndrome [PDF]

open access: yesLancet, The, 2005
1978 www.thelancet.com Vol 366 December 3, 2005 Marfan’s syndrome is a multisystem connective tissue disorder of autosomal dominant inheritance. Approximately one in every 5000 individuals is affected, though this figure is probably an underestimate. The condition shows no predilection for any particular race or geographical background.
Arsun Bektaş
exaly   +5 more sources
Some of the next articles are maybe not open access.

Related searches:

Marfan syndrome

Nature Reviews Disease Primers, 2021
Marfan syndrome (MFS) is an autosomal dominant, age-related but highly penetrant condition with substantial intrafamilial and interfamilial variability. MFS is caused by pathogenetic variants in FBN1, which encodes fibrillin-1, a major structural component of the extracellular matrix that provides support to connective tissues, particularly in arteries,
Dianna M. Milewicz   +8 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy